take phenylpropanolamine off the market

December 2000

The FDA's decision to take phenylpropanolamine off the market is causing quite a stir.

Patients are asking for alternates now that PPA is associated with a risk of hemorrhagic stroke...especially in young women.

There are plenty of allergy and cold meds that use different decongestants than phenylpropanolamine (PPA).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote